The RNA and molecular pathology (RAMP) research group is studying underlying disease mechanisms in autoimmune disorders and cancer. The group has ongoing studies aimed at increasing the understanding of systemic lupus erythematosus (SLE) and lupus nephritis pathology, the role of the long non-coding RNA NEAT1 and paraspeckles in cellular stress responses and breast cancer, and the role of endogenous lipid mediators (resolvins) in the transition from acute to chronic inflammation. We collaborate closely with clinicians and employ state of the art technologies to bring forward novel diagnostic and prognostic markers, and potential targets for therapy in serious human diseases.